Seagen climbs following reports that Merck is nearing deal to buy the company Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Seagen (SGEN) up 4% after The Wall Street Journal reported Merck (MRK) is in advanced discussions to buy the company in a deal that could be worth around $40B or more
- Endeavor Group (EDR) up 2% after Citi analyst Jason Bazinet upgraded the stock to Buy from Neutral with an unchanged price target of $25
- Lamar Advertising (LAMR) up 1% after Bazinet upgraded shares to Buy from Neutral with a price target of $108, down from $112
- GameStop (GME) up 6% after announcing that its board of directors has approved and declared a four-for-one split of the company's Class A common stock in the form of a stock dividend. company stockholders of record at the close of business on July 18
- Virgin Galactic (SPCE) up 4% after reporting an agreement with Aurora Flight Sciences, a Boeing (BA) company, to partner in the design and manufacturing of the company's next generation motherships
UP AFTER EARNINGS -
DOWN AFTER EARNINGS -
- Helen of Troy (HELE) down 9%
LOWER -
- Merck (MRK) down 1% after WSJ reported the company is in advanced discussions to buy Seagen in a deal that could be worth around $40B or more
- Consolidated Communications (CNSL) down 5% after Citi analyst Michael Rollins downgraded the stock to Sell from Neutral with an unchanged price target of $5
- DiaMedica Therapeutics (DMAC) down 36% after the company announced the FDA has placed a clinical hold on the ReMEDy2 stroke study
- CytomX Therapeutics (CTMX) down 24% after the company reported results from a trial of CX-2009 in certain types of breast cancer
Symbols:
SGEN EDR LAMR GME SPCE ENSV HELE MRK CNSLConsolidated Communications
DMAC BA CTMX Keywords: Fly Intel, Wall Street, Top Stories, Stocks